First-Line Ribociclib Plus Letrozole for Postmenopausal Women with HR+, HER2-ABC: Manaleesa-2 Safety Results. (November 2017) - Janni, Wolfgang; Chan, Arlene; Nusch, Arnd; Alba, Emilio; Bachelot, Thomas; Gil-Gil, Miguel; Kattan, Joseph; Bourgeois, Hugues; El Karak, Fadi; Sutradhar, Santosh; Miller, Michelle; Chandiwana, David; et al.